Benutzer: Gast  Login
Titel:

Enoxaparin and rivaroxaban have different effects on human mesenchymal stromal cells in the early stages of bone healing.

Dokumenttyp:
Journal Article
Autor(en):
Pilge, H; Fröbel, J; Prodinger, P M; Mrotzek, S J; Fischer, J C; Zilkens, C; Bittersohl, B; Krauspe, R
Abstract:
Venous thromboembolism (VTE) is a major potential complication following orthopaedic surgery. Subcutaneously administered enoxaparin has been used as the benchmark to reduce the incidence of VTE. However, concerns have been raised regarding the long-term administration of enoxaparin and its possible negative effects on bone healing and bone density with an increase of the risk of osteoporotic fractures. New oral anticoagulants such as rivaroxaban have recently been introduced, however, there is...     »
Zeitschriftentitel:
Bone Joint Res
Jahr:
2016
Band / Volume:
5
Heft / Issue:
3
Seitenangaben Beitrag:
95-100
Sprache:
eng
Volltext / DOI:
doi:10.1302/2046-3758.53.2000595
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/26989119
TUM Einrichtung:
Klinik und Poliklinik für Orthopädie und Sportorthopädie
 BibTeX